References of "Lancellotti, Patrizio"
     in
Bookmark and Share    
Peer Reviewed
See detailHeart Team Session
PIERARD, Luc ULiege; LANCELLOTTI, Patrizio ULiege; PETERMANS, Jean ULiege et al

Conference (2016, August)

Detailed reference viewed: 32 (3 ULiège)
Full Text
Peer Reviewed
See detailRecommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
Nagueh, Sherif F.; Smiseth, Otto A.; Appleton, Christopher P. et al

in European Heart Journal - Cardiovascular Imaging (2016)

Detailed reference viewed: 28 (1 ULiège)
Full Text
Peer Reviewed
See detailPulmonary pressures and outcome in primary mitral regurgitation. Paradigm shift from Rung to Ladder
LANCELLOTTI, Patrizio ULiege; MARTINEZ, Christophe ULiege; Bernard, Alice ULiege

in Journal of the American College of Cardiology (2016), 67(25), 2962-2964

Detailed reference viewed: 18 (3 ULiège)
Full Text
Peer Reviewed
See detail2015 ESC Guidelines on the management of infective endocarditis: a big step forward for an old disease.
Habib, Gilbert; Lancellotti, Patrizio ULiege; Iung, Bernard

in Heart (British Cardiac Society) (2016), 102(13), 992-4

Detailed reference viewed: 25 (1 ULiège)
Full Text
Peer Reviewed
See detailTricuspid Annular Size and Regurgitation Progression After Surgical Repair for Degenerative Mitral Regurgitation.
Sordelli, Chiara; Lancellotti, Patrizio ULiege; Carlomagno, Guido et al

in American Journal of Cardiology (2016)

The late worsening of nonsevere tricuspid regurgitation (TR) after mitral valve surgery is a relevant clinical problem that can lead to high-risk reoperation. Although tricuspid annulus (TA) dilatation ... [more ▼]

The late worsening of nonsevere tricuspid regurgitation (TR) after mitral valve surgery is a relevant clinical problem that can lead to high-risk reoperation. Although tricuspid annulus (TA) dilatation has been proposed for prophylactic annuloplasty to prevent TR worsening, prospective data in degenerative mitral regurgitation (MR) are lacking. The aim of this prospective cohort study was to evaluate TA dimension to predict TR progression after valve repair for degenerative MR. Clinical and echocardiographic evaluation of 706 patients with degenerative MR and no significant TR was obtained preoperatively and at follow-up after isolated mitral valve repair. Together with standard cardiac chamber and valve analysis, 3-dimensional (3D) transesophageal echocardiography was performed to evaluate TA, including the anteroposterior and septolateral diameters. After a mean follow-up of 24 +/- 15 months (range 6 to 60), 2 patients died while 14 developed severe MR. Compared with preoperative values, TR decreased (</=1 degree) in 227 patients, was unchanged in 437, and increased (>/=1 degree) in 39 patients, with the development of significant TR (3 to 4 degree) in 3 patients. Receiver-operating characteristic curve analysis did not identify significant TA values predicting postoperative TR worsening. On multivariate regression analysis, recurrent MR and pulmonary hypertension at follow-up emerged as significant positive predictors of TR progression. Newly developed significant TR is a rare event after successful repair of degenerative MR. Although more accurate than conventional 2D measurement, 3D analysis of TA does not predict early to midterm subsequent TR progression. [less ▲]

Detailed reference viewed: 27 (1 ULiège)
Full Text
Peer Reviewed
See detailJoint EACVI HIT/EAPCI young survey/ESC CoT survey: training and education for 'multimodality imaging in structural interventions': the rise of a new sub-specialty?
Grapsa, Julia; Kunadian, Vijay; Capodanno, Davide et al

in European Heart Journal - Cardiovascular Imaging (2016)

Detailed reference viewed: 47 (1 ULiège)
Full Text
Peer Reviewed
See detailAortic Stenosis Grading and Outcome: New Categories, New Therapeutic Challenges.
Lancellotti, Patrizio ULiege; Davin, Laurent; Dulgheru, Raluca

in JACC. Cardiovascular Imaging (2016)

Detailed reference viewed: 24 (1 ULiège)
Full Text
Peer Reviewed
See detailCriteria for recommendation and expert consensus papers: from the European Association of Cardiovascular Imaging Scientific Documents Committee.
Edvardsen, Thor; Cardim, Nuno; Cosyns, Bernard et al

in European Heart Journal - Cardiovascular Imaging (2016)

The recommendations given in this document are intended as a guide for the writing committees with the aim to harmonize the style and content of EACVI expert consensus and recommendation documents.

Detailed reference viewed: 25 (1 ULiège)
Full Text
Peer Reviewed
See detailPulmonary Hypertension in Aortic Stenosis and Mitral Regurgitation: Rest and Exercise Echocardiography Significance.
Martinez, Christophe; Bernard, Anne; Dulgheru, Raluca et al

in Progress in Cardiovascular Diseases (2016), 59(1), 59-70

Valvular heart disease is a common cause of increased mean pulmonary artery pressure (PAP). Aortic stenosis and mitral regurgitation are frequently accompanied by pulmonary hypertension (PH), especially ... [more ▼]

Valvular heart disease is a common cause of increased mean pulmonary artery pressure (PAP). Aortic stenosis and mitral regurgitation are frequently accompanied by pulmonary hypertension (PH), especially when they are severe and symptomatic. In asymptomatic patients, PH is rare, though the exact prevalence is unknown and mainly stems from the severity of the valvular heart disease and the presence of diastolic dysfunction. Exercise echocardiography has recently gained interest in depicting PH. In these asymptomatic patients, exercise PH is observed in about >40%. Either PH at rest (systolic PAP >50 mmHg) or during exercise (systolic PAP >60 mmHg) is a powerful determinant of outcome and is independently associated with reduced survival, regardless of the severity of the underlying valvular pathology. [less ▲]

Detailed reference viewed: 39 (1 ULiège)
Full Text
Peer Reviewed
See detailThe use of imaging in new transcatheter interventions: an EACVI review paper.
Zamorano, Jose; Goncalves, Alexandra; Lancellotti, Patrizio ULiege et al

in European Heart Journal - Cardiovascular Imaging (2016), 17(8), 835-835

Transcatheter therapies for the treatment of valve heart diseases have expanded dramatically over the last years. The new developments and improvements in devices and techniques, along with the increasing ... [more ▼]

Transcatheter therapies for the treatment of valve heart diseases have expanded dramatically over the last years. The new developments and improvements in devices and techniques, along with the increasing expertise of operators, have turned the catheter-based approaches for valvular disease into an established treatment option. Various imaging techniques are used during these procedures, but echocardiography plays an essential role during patient selection, intra-procedural monitoring, and post-procedure follow-up. The echocardiographic assessment of patients undergoing transcatheter interventions places demands on echocardiographers that differ from those of the routine evaluation of patients with valve disease, and there is a need for specific expertise for those working in the cath lab. In the context of the current rapid developments and growing use of transcatheter valve therapies, this document intends to update the previous recommendations and address new advancements in imaging, particularly for those involved in any stage of the treatment of patients with valvular heart diseases. [less ▲]

Detailed reference viewed: 30 (1 ULiège)
Full Text
Peer Reviewed
See detailTwo-dimensional transthoracic echocardiographic normal reference ranges for proximal aorta dimensions: results from the EACVI NORRE study.
Saura, Daniel; Dulgheru, Raluca; Caballero, Luis et al

in European Heart Journal - Cardiovascular Imaging (2016)

AIMS: To report normal reference ranges for echocardiographic dimensions of the proximal aorta obtained in a large group of healthy volunteers recruited using state-of-the-art cardiac ultrasound equipment ... [more ▼]

AIMS: To report normal reference ranges for echocardiographic dimensions of the proximal aorta obtained in a large group of healthy volunteers recruited using state-of-the-art cardiac ultrasound equipment, considering different measurement conventions, and taking into account gender, age, and body size of individuals. METHODS AND RESULTS: A total of 704 (mean age: 46.0 +/- 13.5 years) healthy volunteers (310 men and 394 women) were prospectively recruited from the collaborating institutions of the Normal Reference Ranges for Echocardiography (NORRE) study. A comprehensive echocardiographic examination was obtained in all subjects following pre-defined protocols. Aortic dimensions were obtained in systole and diastole, following both the leading-edge to leading-edge and the inner-edge to inner-edge conventions. Diameters were measured at four levels: ventricular-arterial junction, sinuses of Valsalva, sino-tubular junction, and proximal tubular ascending aorta. Measures of aortic root in the short-axis view following the orientation of each of the three sinuses were also performed. Men had significantly larger body sizes when compared with women, and showed larger aortic dimensions independently of the measurement method used. Dimensions indexed by height and body surface area are provided, and stratification by age ranges is also displayed. In multivariable analysis, the independent predictors of aortic dimensions were age, gender, and height or body surface area. CONCLUSION: The NORRE study provides normal values of proximal aorta dimensions as assessed by echocardiography. Reference ranges for different anatomical levels using different (i) measurement conventions and (ii) at different times of the cardiac cycle (i.e. mid-systole and end-diastole) are provided. Age, gender, and body size were significant determinants of aortic dimensions. [less ▲]

Detailed reference viewed: 33 (1 ULiège)
Full Text
Peer Reviewed
See detailLa cardiotoxicité des traitements anti-cancéreux
FRERES, Pierre ULiege; PONCIN, Aurélie ULiege; MOONEN, Marie ULiege et al

in Revue Médicale de Liège (2016), 71(9), 382-387

Les cancers sont de plus en plus fréquents et leurs traitements de plus en plus agressifs. En conséquence, les médecins se trouvent régulièrement confrontés aux effets secondaires des traitements ... [more ▼]

Les cancers sont de plus en plus fréquents et leurs traitements de plus en plus agressifs. En conséquence, les médecins se trouvent régulièrement confrontés aux effets secondaires des traitements cytotoxiques. La cardiotoxicité induite par les traitements anti-cancéreux est une complication gravissime, car elle peut être mortelle et provoque un arrêt temporaire, voire définitif, des traitements. Dans cet article, nous décrivons les mécanismes, le dépistage et la prise en charge multidisciplinaire de la cardiotoxicité des agents anti-cancéreux. [less ▲]

Detailed reference viewed: 44 (12 ULiège)
Full Text
Peer Reviewed
See detailMicroRNAs in Valvular Heart Diseases: Potential Role as Markers and Actors of Valvular and Cardiac Remodeling.
Oury, Cécile ULiege; Servais, Laurence ULiege; Bouznad, Nassim et al

in International Journal of Molecular Sciences (2016), 17(7),

miRNAs are a class of over 5000 noncoding RNAs that regulate more than half of the protein-encoding genes by provoking their degradation or preventing their translation. miRNAs are key regulators of ... [more ▼]

miRNAs are a class of over 5000 noncoding RNAs that regulate more than half of the protein-encoding genes by provoking their degradation or preventing their translation. miRNAs are key regulators of complex biological processes underlying several cardiovascular disorders, including left ventricular hypertrophy, ischemic heart disease, heart failure, hypertension and arrhythmias. Moreover, circulating miRNAs herald promise as biomarkers in acute myocardial infarction and heart failure. In this context, this review gives an overview of studies that suggest that miRNAs could also play a role in valvular heart diseases. This area of research is still at its infancy, and further investigations in large patient cohorts and cellular or animal models are needed to provide strong data. Most studies focused on aortic stenosis, one of the most common valvular diseases in developed countries. Profiling and functional analyses indicate that miRNAs could contribute to activation of aortic valve interstitial cells to a myofibroblast phenotype, leading to valvular fibrosis and calcification, and to pressure overload-induced myocardial remodeling and hypertrophy. Data also indicate that specific miRNA signatures, in combination with clinical and functional imaging parameters, could represent useful biomarkers of disease progression or recovery after aortic valve replacement. [less ▲]

Detailed reference viewed: 20 (4 ULiège)
Full Text
Peer Reviewed
See detailRecommandations européennes sur la prise en charge de l’endocardite infectieuse (partim 1)
IOVINO, Alessandra ULiege; MARCHETTA, Stella ULiege; DULGHERU, Raluca Elena ULiege et al

in Revue Médicale de Liège (2016), 71(6), 281-286

Detailed reference viewed: 20 (4 ULiège)
Full Text
Peer Reviewed
See detail2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, Piotr; Voors, Adriaan A.; Anker, Stefan D. et al

in European Heart Journal (2016)

Detailed reference viewed: 28 (3 ULiège)
Full Text
Peer Reviewed
See detail2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, Piotr; Voors, Adriaan A.; Anker, Stefan D. et al

in European Journal of Heart Failure (2016)

Detailed reference viewed: 25 (2 ULiège)
Full Text
Peer Reviewed
See detail2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, Massimo F.; Hoes, Arno W.; Agewall, Stefan et al

in European Heart Journal (2016)

Detailed reference viewed: 34 (2 ULiège)